Japan’s Nikkei share average rose for the first time this week on Friday as investors took heart from reports that the United States and the European Union may agree to suspend auto tariffs, triggering short-covering on cyclical shares like automakers.
Drugmaker Eisai Co was in the spotlight, jumping 19 percent after it and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer’s drug showed positive results for patients who received the highest dose.
The Nikkei rose 0.8 percent to 21,720.41 in midmorning trade, snapping a four-day losing streak. The index has dropped 2.9 percent for the week so far, heading for a third straight weekly decline. The broader Topix rose 0.6 percent to 1,685.66.
Source : Reuters